Archives des NEWS

The HES-SO Valais-Wallis strengthens its national positioning in Life Sciences

The HES-SO Valais-Wallis School of Engineering is today unveiling a major change in the way it promotes its educational offerings and research and innovation skills in the life sciences sector.
Over the past few years, the Swiss biopharmaceutical and food industries have undergone a rapid shift towards life sciences. Driven by innovation, collaboration and a commitment to health, wellbeing and sustainability, a number of partner companies of the Swiss College of Engineering (HEI), such as Debiopharm and Lonza, have massively expanded these business areas to meet the needs of the economy.

BioArk welcomes a Global Village delegation April 2024 !

The Valais life sciences ecosystem is in the spotlight this year, as the BioArk Monthey technology site will be a major stop for the delegation on Wednesday April 24. International players will be welcomed on our Monthey-Site, on April 24th.The Global Village is a platform hosted by the Swiss Biotech Association, in partnership with other Swiss …

BioArk welcomes a Global Village delegation April 2024 ! Read More »

2024: a promising year for biotech

In a recent article published in the Agefi, the year 2023 saw a rise in mergers and acquisitions in the biotech sector, despite a slowdown in IPOs. While 2024 promises to be an optimistic year, investors are urged to be cautious about the haste of start-ups to go public.

IHMA Exhibiting and Presenting at ECCMID 2024

Meet IHMA at the 2024 ECCMID conference in Barcelona from April 27 to 30, 2024. Rendez-vous at the booth Stand E67 ! Based on the Monthey-site of BioArk, the company IHMA is specialized in infectious diseases & offer the most comprehensive offering of products and services for developing and marketing antimicrobial agents. From April 27 …

IHMA Exhibiting and Presenting at ECCMID 2024 Read More »

Orio Therapeutics Secures CHF 500’000 Pre-Seed Funding to Fuel the Development of Cardioprotective Therapy

Orio Therapeutics, a biotechnology company at the forefront of protein engineering for regenerative medicine, today announced the successful closure of a CHF 500,000 pre-seed funding round. This investment, secured from angel investors, will propel the company’s ambitious goal of revolutionizing treatment approaches for patients suffering from debilitating conditions.

ten23 health and SHL Medical announce a strategic partnership agreement for integrated services

ten23 health, based in Basel and at the BioArk Visp, and SHL Medical, a world-leading provider of drug delivery devices, announced their strategic partnership to provide a streamlined offering for pharmaceutical and biotech companies that require sterile drug/device combination products.

MINTworld celebrates a successful first year

Presse release – Visp, Switzerland, March 22, 2024 – In March 2023, MINTworld, a platform dedicated to discovery and innovation, was inaugurated in Visp. In a public-private partnership, the canton of Valais, BioArk Viège AG and Lonza are committed to promoting the enjoyment of technology and science within the community, and to creating a platform …

MINTworld celebrates a successful first year Read More »

ten23 health’s expansion in Visp will be operational by en 2024 !

Swiss CDMO ten23 health has announced in its press release that its large-scale pre-filled syringe, cartridge and vial aseptic filling line 2 (VIVA2) in Visp (Switzerland) will be GMP operational by end 2024! Located near by our Visp technological site of BioArk, the ten23 Health’s expansion, previously first announced in June, 2022 is now completing …

ten23 health’s expansion in Visp will be operational by en 2024 ! Read More »

Get to know the new Probiota Pionneer: REM Analytics !

The past week has been a landmark occasion for the Monthey startup REM Analytics, as they were selected to present their cutting-edge Advanced Testing for Genetic Composition technology platform on stage at the major Probiota 2024 congress. Discover this innovative nugget and its technology ! First of all, a few words about REM Analytics. …

Get to know the new Probiota Pionneer: REM Analytics ! Read More »

Monthey City acquires the Djeva site for BioArk future technology park

The purpose of this exchange between the municipality of Monthey and Satom is twofold. A large part of the site of the former Djevahirdjian factory, which closed its doors in 2021 after one hundred and seven years of activity in the manufacture of synthetic gemstones, is now in municipal hands. The Satom company, which had …

Monthey City acquires the Djeva site for BioArk future technology park Read More »

NEWS

Contact

Start typing and press enter to search